Catamaran and OptumRx to Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- US stock futures tick higher as tech steadies though oil, yields stay high
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
UnitedHealth Group (UNH) PT Lifted to $135 at Credit Suisse
March 31, 2015 7:36 AM EDTCredit Suisse reiterated an Outperform rating and boosted its price target on UnitedHealth Group (NYSE: UNH) to $135.00 (from $120.00) after the deal to acquire Catamaran for approx. $13.5 billion.
The company's estimate of $0.30 accreation to 2016 EPS appears conservative analyst R. Giacobbe. In... More
OptumRx to Acquire Catamaran (CTRX) for $61.50/Share (UNH)
March 30, 2015 6:17 AM EDTOptumRx and Catamaran Corporation (Nasdaq: CTRX) announced that they have agreed to combine. OptumRx is UnitedHealth Groups (NYSE: UNH) free-standing pharmacy care services business.
The agreement calls for the acquisition of Catamarans outstanding common stock for $61.50 per share in cash. The transaction is expected to close during the fourth quarter of 2015, subject to Catamaran shareholders approval, regulatory approvals and other customary closing conditions. The combination diversifies OptumRxs customer and business mix, while accelerating its technology leadership and flexible service offerings.
The acquisition is... More
